TAG:
laboratory executive
Tenet, SBCL Discussing 33 Hospital Lab Contract
By Robert Michel | From the Volume IV No. 16 – November 17, 1997 Issue
CEO SUMMARY: Tenet Healthcare’s decision to entertain proposals for improving laboratory operations in its Southern California division triggered a year-long discussion with national laboratories. If a deal results, it would represent one of the largest “re-engineering†projects bet…
California’s Rumor Mill Links LabCorp & Unilab
By Robert Michel | From the Volume IV No. 15 – October 27, 1997 Issue
CEO SUMMARY: Continued financial pressure on all laboratories operating in California leads some industry observers to believe that Laboratory Corporation of America and Unilab might be considering some kind of deal between the two companies. Senior executives at both laboratories say suc…
Consolidation Within The Diagnostics Industry
By R. Lewis Dark | From the Volume IV No. 14 – October 6, 1997 Issue
IN THIS ISSUE WE ARE GIVING COVERAGE to the acquisition of Coulter Corporation by Beckman Instruments, Inc. for an important reason. I believe this merger is first evidence of impending and significant changes to the diagnostics industry. During the next 18 to 24 m…
Lab Market Trends Drive Beckman-Coulter Deal
By Robert Michel | From the Volume IV No. 14 – October 6, 1997 Issue
CEO SUMMARY: Laboratory executives should pay attention to Beckman’s acquisition of Coulter. Together, both companies service a sizeable base of laboratory customers. Any changes to products and services resulting from this merger will affect a large number of clinical laboratories. Obs…
Diagnostic Companies About To Undergo Change
By Robert Michel | From the Volume IV No. 14 – October 6, 1997 Issue
CEO SUMMARY: Diagnostic companies are undergoing the same consolidation wave as commercial laboratories and hospitals. Beckman’s acquisition of Coulter provides an early example of how diagnostics companies will use acquisitions to create a comprehensive product line. Other surprising m…
Nominations Now Open For Laboratory Innovators
By Robert Michel | From the Volume IV No. 14 – October 6, 1997 Issue
CEO SUMMARY: Nominations are now open as THE DARK REPORT seeks to identify laboratory executives who deserve recognition. Our annual awards program honors the innovators and leaders within the clinical laboratory industry who push the boundaries of management change and show us how to bes…
LabCorp Hosts DARK REPORT For Burlington Site Visit
By Robert Michel | From the Volume IV No. 13 – September 15, 1997 Issue
CEO SUMMARY: During the years of sustained bad financial news that dogged the major laboratories, there was a reluctance to speak publicly about any aspect of the laboratory business. That era seems to be ending, as LabCorp and the other national laboratories become friendlier and more ac…
Warning Ahead: Investigation And Litigation
By R. Lewis Dark | From the Volume IV No. 12 – August 25, 1997 Issue
NEWS THAT PRIVATE INSURERS FILED A MAJOR LAWSUIT against SmithKline Beecham last Thursday confirms something I’ve wondered about for several years. What would be the private insurer’s perspective on the same laboratory billing and reimbursement practices which triggered federal settlements with …
Issues At Columbia/HCA Exist At Other Hospitals
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Even as federal regulators attract big headlines in their investigation of Columbia/HCA, laboratory administrators in a variety of hospital settings may be surprised in the future to find federal investigators scrutinizing the billing practices at their institution. Columbiaâ…
Private Insurers Sue SmithKline, Feds Pursue Labs In Six States
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
FRAUD AND ABUSE for laboratory billing is an issue which refuses to disappear. Private insurers filed a lawsuit against SmithKline Beecham last Thursday, seeking unspecified damages related to overcharging for laboratory testing during the years 1989-1995. At the same time, news eme…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized